Project Details
Abstract
Epstein-Barr vrius (EBV) infects B lymphocyte and epithelial cells. The infections are
commonly persistent and latent. However, the virus must go through a lytic stage to produce
progenies to establish new infections. During the lytic cycle, large amounts of viral DNA and
proteins are produced, then DNA is packaged into capsid in the nucleus. Viral glycoprotein-
embedded envelope then adds onto the nucleocapsid during maturation: including processes of
primary envelopment, de-envelopment and final envelopment. Our earlier study showed
BBLF1 involves in final envelopment. However, exact how the protein influences the process
is unclear. My recent study identifies that viral BGLF2, a tegument protein associated with
capsids, interacts with BBLF1, and the interaction promotes cytosolic BGLF2 translocation to
the TGN membrane, where BBLF1 and viral glycoproteins are present. Therefore, this study
posits that BBLF1 acts as bridge by interacting with BGLF2 and glycoproteins, thus recruiting
BGLF2-coated capsids to glycoprotein-embedded TGN membrane. Ultimately, the
interactions among BBLF1, BGLF2, and glycoprotein on TGN membrane promote the
budding of capsids into lumen. Therefore, this project will investigate the interactions among
BBLF1, BGLF2 and glycoproteins and how the interaction influence maturation. BBLF1 is
dual-acylated modified protein located at the TGN and most likely on the lipid raft, suggesting
that lipid rafts may serve as a platform during final envelopment. The relationship between
lipid rafts and final envelopment and the mechanism of glycoprotein targeting to TGN or lipid
raft will be investigated. Additionally, our study observed the number of autophagosome is
increased during EBV lytic cycle, and EBV glycoprotein gp350/220 colocalizes with an
autophagosomal marker, GFP-LC3. Using Atg5 siRNA to attenuate cellular autophagic
activity lead to a reduction in virus particles, but enhancement in virion infectivity. Since the
glycoproteins on virion in quantity and quality are crucial for EBV infection, This study will
investigate how autophagy affect packaging of glycoprotein during final envelopment, which
will affect virion infectivity. The results from study will provide a better understanding in final
envelopment during EBV lytic cycle.
Project IDs
Project ID:PC10308-1890
External Project ID:MOST103-2320-B182-013
External Project ID:MOST103-2320-B182-013
Status | Finished |
---|---|
Effective start/end date | 01/08/14 → 31/07/15 |
Keywords
- Epstein-Barr virus
- final envelopment
- BBLF1
- BGLF2
- autophagy
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.